22 Mar 2010 GlaxoSmithKline Statement on New Information Relating to Manufacture of Rotarix (Rotavirus Vaccine)
18 Mar 2010 Novartis receives approval in the European Union for Menveo, first quadrivalent conjugate vaccine in the EU to help prevent meningococcal disease
18 Mar 2010 Genocea Biosciences Signs Exclusive License Agreement with Children’s Hospital Boston for Novel Streptococcus Pneumoniae Antigens
17 Mar 2010 Study Shows Prevenar 13 Is Immunogenic In Young Children Previously Vaccinated With Prevenar
17 Mar 2010 Nabi Biopharmaceuticals Initiates Second Phase III Study for NicVAX as an Aid to Smoking Cessation and Long-term Abstinence
16 Mar 2010 Dynavax Anticipates Earlier BLA Submission for HEPLISAV(TM)
15 Mar 2010 Vacc-C5 to be prepared for phase I/II clinical trial
15 Mar 2010 Initiation of Two Phase II Studies with Ipsen's Proprietary BIM 23A760 First-in-Class Chimeric Compound in the Treatment of Acromegaly and Carcinoid Syndrome Due to Neuroendocrine Tumors
12 Mar 2010 Baxter Presents Clinical Efficacy Results from Phase III Study of Seasonal Flu Vaccine
11 Mar 2010 BioSante Announces Positive Leukemia Vaccine Results
10 Mar 2010 ImmunoCellular Therapeutics’ Dendritic Cell-Based Vaccine Demonstrates Statistically Significant Increase in Survival in an Animal Model of Glioblastoma
09 Mar 2010 Bavarian Nordic Successfully Completes End of Phase II Meeting for PROSTVAC
08 Mar 2010 Argos Therapeutics Presents Positive Phase 2 Data of its Arcelis™ Personalized Immunotherapy Platform in Metastatic RCC at ASCO GU Symposium
04 Mar 2010 Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival in Patients With Metastatic Castrate-Resistant Prostate Cancer
04 Mar 2010 BioVex Initiates Phase 1 Clinical Trial with Its Genital Herpes Vaccine, ImmunoVEXHSV2
03 Mar 2010 Merck Reports Results of Phase III Study of Investigational Oral Allergy Immunotherapy Tablet (AIT) in Patients Ages 5-17 with Grass Pollen Allergy
25 Feb 2010 AFFiRiS AG: vaccination against hypertension is development project no. 4 and has already been awarded an FFG grant of up to 1.2 million.
24 Feb 2010 Pfizer Receives FDA Approval for Prevnar 13 for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children
24 Feb 2010 Publication of Vical's H5N1 Results Paves the Way for H1N1 Clinical Trial
23 Feb 2010 GlycoVaxyn's First Clinical Study with Bioconjugate Vaccine Initiated
22 Feb 2010 Cyto Pulse, the Karolinska Institute and the Swedish Institute for Infectious Disease Control Receive Phase I Clinical Trial Approval from the Swedish Medical Products Agency to Evaluate an HIV Vaccine in Healthy Volunteers
22 Feb 2010 CEL-SCI Study Shows CEL-2000 Vaccine Blocks Progression of Rheumatoid Arthritis
22 Feb 2010 Novartis receives FDA approval of Menveo®, a vaccine to prevent meningococcal disease
19 Feb 2010 Sanofi Pasteur’s A(H1N1) Vaccine Humenza Recommended by European Medicines Agency
19 Feb 2010 NOVAVAX Presents Positive Clinical Results at The World Health Organization Conference, Geneva, Switzerland

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up